GO:1903914 negative regulation of fusion of virus membrane with host plasma membrane: Viral Entry Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903914 describes any process that stops, prevents, or reduces the frequency, rate, or extent of fusion between a virus membrane and the host plasma membrane.
• This term is a biological process node that sits upstream of viral entry and is critical for host defense and therapeutic intervention.
• Key host restriction factors such as IFITM proteins directly inhibit viral membrane fusion at the plasma membrane.
• Calcium ions and endosomal pH can modulate fusion efficiency, and negative regulators often target these cofactors.
• Viruses have evolved countermeasures, including hijacking ESCRT-III and VPS4A to promote membrane remodeling and evade restriction.
• CRISPR knockout, point mutation, and overexpression models are essential to dissect the causal role of candidate negative regulators.
Description
The fusion of a virus membrane with the host plasma membrane is a decisive step in viral entry for enveloped viruses, and its negative regulation constitutes a critical host defense mechanism. GO:1903914, negative regulation of fusion of virus membrane with host plasma membrane, captures any process that stops, prevents, or reduces the frequency, rate, or extent of this fusion event. This term is essential for researchers studying viral pathogenesis, host restriction factors, and the development of antiviral strategies that block entry before infection is established. Understanding the molecular players that negatively regulate fusion provides a framework for identifying therapeutic targets and for interpreting genome-wide screens that reveal host dependency and restriction factors.
negative regulation of fusion of virus membrane with host plasma membrane At A Glance
| GO ID | GO:1903914 |
|---|---|
| GO term | negative regulation of fusion of virus membrane with host plasma membrane |
| Ontology | biological_process |
| Synonym | inhibition of viral envelope fusion with host plasma membrane; downregulation of viral penetration via membrane fusion; negative regulation of viral-cell fusion molecule activity |
| Major function | Host defense by blocking viral membrane fusion at the plasma membrane |
| Related processes | Viral entry into host cell, membrane fusion, endocytosis, autophagy |
| Key regulators | IFITM proteins, calcium signaling, ESCRT-III/VPS4A, ACE2/TMPRSS2 balance |
| Disease relevance | COVID-19, HIV-1, MERS, classical swine fever, Borna disease |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, pseudovirus fusion assays, imaging, proteomics |
What Is GO:1903914?
In simple terms, GO:1903914 describes the biological brakes that prevent a virus from merging its membrane with the host cell's outer membrane. According to the QuickGO definition, it encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of fusion of virus membrane with host plasma membrane. This includes inhibition of viral-cell fusion molecule activity, negative regulation of viral entry via membrane fusion with the plasma membrane, and negative regulation of viral envelope fusion with host membrane. The term is a child of negative regulation of viral entry into host cell and is distinct from positive regulation or from fusion that occurs within endosomes.
Why Is negative regulation of fusion of virus membrane with host plasma membrane Important in Cell Biology?
GO:1903914 is important because it defines the host mechanisms that can stop a virus before it ever delivers its genome, making it a prime target for broad-spectrum antiviral strategies. Many enveloped viruses, including SARS-CoV-2, HIV-1, and MERS-CoV, depend on plasma membrane fusion or endosomal fusion, and their inhibition by host factors such as IFITM proteins directly determines infectivity. Understanding negative regulation also reveals viral countermeasures, such as ESCRT-III hijacking, that promote fusion and spread. This knowledge is critical for interpreting genome-wide CRISPR screens, designing entry inhibitors, and predicting disease severity linked to host genetic variation.
• Blocks viral entry at the plasma membrane, preventing infection before genome release.
• IFITM proteins are prototype negative regulators with broad anti-viral activity against HIV-1 and other enveloped viruses.
• Calcium ions promote MERS-CoV fusion, so negative regulators may target calcium-dependent steps.
• Viruses like classical swine fever virus hijack ESCRT-III and VPS4A to promote membrane remodeling and evade restriction.
• Host factors such as ACE2, ADAM17, and TMPRSS2 are rhythmically expressed and influence fusion efficiency.
• Herpes simplex virus UL34 mutations affect membrane budding and nuclear lamina disruption, linking fusion regulation to viral assembly.
• Borna disease virus spread from cell to cell involves surface glycoprotein-mediated fusion, which can be negatively regulated.
• Arenavirus entry is a model for understanding fusion inhibition and therapeutic targeting.
• Phage lysis studies reveal conserved membrane fusion mechanisms that inform eukaryotic viral fusion.
• CRISPR screens can identify novel negative regulators, accelerating antiviral drug discovery.
What Happens During negative regulation of fusion of virus membrane with host plasma membrane?
Recognition and Receptor Binding Interference
In simple terms: The host cell can block the virus before it even touches the fusion machinery.
Negative regulation can occur at the receptor-binding step, where host factors mask or downregulate receptors such as ACE2, preventing the virus from engaging the fusion trigger. For example, IFITM proteins may alter membrane fluidity or receptor clustering, reducing the efficiency of viral envelope fusion with the host plasma membrane. In addition, calcium ions promote MERS-CoV fusion, so negative regulators that chelate calcium or modulate calcium channels can inhibit fusion.
Membrane Remodeling and Lipid Composition Changes
In simple terms: The cell changes its membrane so the virus cannot merge with it.
Host cells can modify plasma membrane lipid composition, including cholesterol and sphingolipid content, to create a fusion-resistant environment. IFITM proteins are known to block fusion by altering membrane order and curvature, thereby preventing the formation of fusion pores. In parallel, ESCRT-III and VPS4A are hijacked by classical swine fever virus to promote phagophore closure and mitophagy, which can indirectly enhance viral spread by modulating membrane dynamics. Negative regulation thus involves active membrane remodeling that opposes viral fusion.
Direct Inhibition of Fusion Protein Activity
In simple terms: The cell makes proteins that directly jam the viral fusion machinery.
Some host proteins directly bind to viral fusion glycoproteins and prevent conformational changes required for membrane merger. For instance, IFITM proteins restrict HIV-1 fusion by interfering with the viral envelope glycoprotein-mediated hemifusion step. Similarly, the surface glycoprotein of Borna disease virus mediates cell-to-cell spread, and its activity can be negatively regulated by host factors that block glycoprotein processing or trafficking. These direct interactions are a major mechanism of GO:1903914.
Viral Countermeasures and Evasion
In simple terms: Viruses fight back by hijacking cellular machinery to promote fusion.
Viruses have evolved strategies to overcome negative regulation. Classical swine fever virus hijacks ESCRT-III and VPS4A to promote phagophore closure and accelerate mitophagy, which may create a favorable environment for viral replication and spread. Herpes simplex virus 1 UL34 mutants affect membrane budding regulation and nuclear lamina disruption, indicating that viral proteins can modulate host membrane fusion machinery. Arenaviruses also use alternative entry routes to bypass restriction. Understanding these countermeasures is essential for designing drugs that target fusion.
Calcium and pH-Dependent Regulation
In simple terms: The cell controls the chemical conditions that the virus needs to fuse.
Calcium ions promote fusion of MERS-CoV with host cells and increase infectivity, so negative regulators may act by lowering cytosolic calcium or altering endosomal pH. The renin-angiotensin system and daily rhythms in ACE2, ADAM17, and TMPRSS2 expression also influence the fusion microenvironment. These physiological parameters are integrated into the negative regulation of viral membrane fusion, providing additional layers of control.
Key Genes Involved in GO:1903914 negative regulation of fusion of virus membrane with host plasma membrane
The following genes and proteins are experimentally implicated in the negative regulation of fusion of virus membrane with host plasma membrane, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IFITM1 | Blocks HIV-1 fusion at the plasma membrane | Prototype restriction factor; KO increases fusion |
| IFITM2 | Inhibits viral envelope fusion | Functional heterogeneity against HIV-1 |
| IFITM3 | Broad-spectrum inhibitor of viral fusion | Key negative regulator; overexpression reduces infectivity |
| ACE2 | Receptor for SARS-CoV-2; downregulation reduces fusion | Rhythmic expression affects entry |
| ADAM17 | Sheddase that regulates ACE2 levels | Modulates fusion efficiency |
| TMPRSS2 | Protease that primes viral fusion proteins | Negative regulators may inhibit its activity |
| VPS4A | ESCRT-III component hijacked by CSFV | Promotes membrane remodeling for viral spread |
| CHMP4B | ESCRT-III subunit involved in membrane scission | Potential target for fusion regulation |
| UL34 | Herpes simplex virus 1 protein affecting budding | Mutants alter membrane fusion and lamina disruption |
| gB | Herpes simplex virus 1 fusion glycoprotein | Target of negative regulation |
| BDV G | Borna disease virus surface glycoprotein | Mediates cell-to-cell spread; can be restricted |
| Arenavirus GP | Arenavirus entry glycoprotein | Model for fusion inhibition |
| MERS-CoV S | Spike protein requiring calcium for fusion | Calcium-dependent negative regulation |
| HIV-1 Env | Envelope glycoprotein mediating fusion | Target of IFITM proteins |
| CSFV E2 | Classical swine fever virus envelope protein | Interacts with ESCRT machinery |
| LAMP1 | Lysosomal marker in mitophagy | Indirectly linked to fusion regulation |
| ATG5 | Autophagy protein involved in phagophore closure | Modulated by CSFV to promote mitophagy |
| RAB7 | Late endosome marker | Affects viral fusion and trafficking |
How Is negative regulation of fusion of virus membrane with host plasma membrane Regulated?
The negative regulation of viral membrane fusion is itself tightly regulated by cellular signaling pathways. Calcium signaling promotes MERS-CoV fusion, so negative regulators that buffer calcium or inhibit calcium channels can suppress fusion. The renin-angiotensin system, with daily rhythms in ACE2, ADAM17, and TMPRSS2 expression, modulates the availability of receptors and proteases required for fusion, thereby influencing the efficiency of negative regulation. Autophagy-related proteins such as ATG5 and ESCRT-III components like VPS4A are hijacked by viruses to promote membrane remodeling, which can override negative regulation. Additionally, interferon signaling induces IFITM proteins, which are direct negative regulators of fusion. Thus, the process is controlled at the levels of receptor availability, ion homeostasis, membrane lipid composition, and interferon-stimulated gene expression.
negative regulation of fusion of virus membrane with host plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IFITM3 | HIV-1 restriction | IFITM3 KO and overexpression in T cells |
| ACE2 | COVID-19 susceptibility | ACE2 knock-in mouse or human organoids |
| TMPRSS2 | SARS-CoV-2 entry | TMPRSS2 KO lung epithelial cells |
| VPS4A | Classical swine fever virus spread | VPS4A KO porcine cells |
| UL34 | Herpes simplex virus 1 budding | UL34 mutant virus infection |
COVID-19 and MERS
SARS-CoV-2 and MERS-CoV entry depends on plasma membrane fusion or endosomal fusion, and negative regulators such as IFITM proteins can block this step. Calcium ions promote MERS-CoV fusion, and daily rhythms in ACE2, ADAM17, and TMPRSS2 expression influence susceptibility. Therapeutic strategies that enhance negative regulation could reduce viral load and disease severity.
HIV-1 Infection
IFITM proteins exhibit functional heterogeneity against HIV-1, with IFITM1, IFITM2, and IFITM3 differentially restricting fusion at the plasma membrane. Understanding how these negative regulators are evaded or overcome is critical for developing entry inhibitors and for interpreting HIV-1 pathogenesis.
Classical Swine Fever and Borna Disease
Classical swine fever virus hijacks ESCRT-III and VPS4A to promote phagophore closure and mitophagy, enhancing viral spread. Borna disease virus uses its surface glycoprotein to mediate cell-to-cell spread, which can be negatively regulated by host factors. These animal viruses provide models for studying fusion regulation in vivo.
Herpes Simplex Virus
Herpes simplex virus 1 UL34 mutants affect membrane budding regulation and nuclear lamina disruption, linking viral assembly to fusion regulation. Negative regulation of fusion at the nuclear envelope or plasma membrane may influence HSV-1 latency and reactivation.
From negative regulation of fusion of virus membrane with host plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IFITM3 block HIV-1 fusion? | IFITM3 knockout and overexpression in Jurkat cells |
| Is calcium required for MERS-CoV fusion? | Calcium chelation and point mutations in spike |
| Does VPS4A promote CSFV spread? | VPS4A knockout in swine cells |
| How does ACE2 rhythm affect fusion? | ACE2 knock-in with circadian reporters |
| Does UL34 mutation alter membrane fusion? | Recombinant HSV-1 with UL34 point mutations |
| Can IFITM proteins restrict Borna disease virus? | IFITM overexpression in neuronal cells |
How to Study the negative regulation of fusion of virus membrane with host plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pseudovirus fusion assay | Fusion efficiency | Testing IFITM proteins against HIV-1 |
| CRISPR knockout screen | Gene requirement for fusion | Identifying novel restriction factors |
| Live-cell imaging | Kinetics of fusion | Visualizing MERS-CoV fusion with calcium |
| Proteomics | Protein interactions | Finding ESCRT-III components |
| RNA-seq | Transcriptional changes | Interferon-stimulated gene induction |
| Ribo-seq | Translation efficiency | Measuring IFITM protein synthesis |
| Flow cytometry | Infected cell percentage | Quantifying restriction |
| Electron microscopy | Membrane ultrastructure | Observing fusion pores |
Pseudovirus Fusion Assays
Pseudoviruses carrying viral glycoproteins and a reporter gene are used to measure fusion efficiency in the presence or absence of candidate negative regulators. This method allows quantification of GO:1903914 activity by comparing entry in control versus knockout cells.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify host genes that negatively regulate viral fusion. Cells are infected with a virus of interest, and sgRNA enrichment or depletion is measured to pinpoint restriction factors.
Live-Cell Imaging
Fluorescently labeled viruses and membrane dyes enable real-time visualization of fusion events at the plasma membrane. This approach reveals the kinetics of negative regulation and the subcellular localization of restriction factors.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify host proteins that interact with viral fusion glycoproteins, uncovering new negative regulators. Phosphoproteomics can reveal signaling changes during restriction.
How CRISPR Can Be Used to Study GO:1903914 negative regulation of fusion of virus membrane with host plasma membrane
Knockout
CRISPR knockout of candidate negative regulators such as IFITM3 or VPS4A allows researchers to test whether loss of function increases viral fusion and infectivity. This is a direct way to establish causality for GO:1903914.
Point Mutation
Introducing point mutations in viral fusion proteins or host regulators can dissect specific residues required for negative regulation. For example, mutations in the MERS-CoV spike calcium-binding site affect fusion efficiency.
Knock-in
Knock-in of tagged or reporter versions of host restriction factors enables visualization and quantification of their localization and stability during viral challenge. This helps map the spatiotemporal dynamics of negative regulation.
Overexpression
Overexpression of IFITM proteins or other negative regulators can suppress viral fusion and protect cells from infection. This approach is useful for validating restriction factors and for screening small-molecule enhancers of negative regulation.
How EDITGENE Supports negative regulation of fusion of virus membrane with host plasma membrane Research
Researchers studying negative regulation of fusion of virus membrane with host plasma membrane-related genes often need to determine whether a candidate gene is causally involved in restricting viral entry or is merely a bystander. EDITGENE provides the precise CRISPR tools and services required to establish causality, from knockout to knock-in and overexpression models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of fusion of virus membrane with host plasma membrane research.
Frequently Asked Questions About negative regulation of fusion of virus membrane with host plasma membrane
What is GO:1903914?
GO:1903914 is a Gene Ontology biological process term that describes any process that stops, prevents, or reduces the frequency, rate, or extent of fusion of virus membrane with host plasma membrane.
What genes are involved in negative regulation of viral membrane fusion?
Key genes include IFITM1, IFITM2, IFITM3, ACE2, ADAM17, TMPRSS2, VPS4A, and CHMP4B, among others.
How do IFITM proteins block viral fusion?
IFITM proteins alter membrane fluidity and block the hemifusion step, preventing the formation of a fusion pore between the viral envelope and host plasma membrane.
Does calcium regulate virus-host membrane fusion?
Yes, calcium ions promote MERS-CoV fusion with host cells and increase infectivity, so negative regulators may act by lowering calcium levels.
What viruses are affected by negative regulation of fusion?
Enveloped viruses such as HIV-1, MERS-CoV, SARS-CoV-2, classical swine fever virus, Borna disease virus, and herpes simplex virus 1 are affected.
How can I study negative regulation of fusion in the lab?
Common methods include pseudovirus fusion assays, CRISPR knockout screens, live-cell imaging, and proteomics.
What is the role of ESCRT-III in viral fusion?
Classical swine fever virus hijacks ESCRT-III and VPS4A to promote phagophore closure and mitophagy, which can enhance viral spread and counteract negative regulation.
Can CRISPR be used to identify new negative regulators?
Yes, genome-wide CRISPR knockout and activation screens have successfully identified host restriction factors that negatively regulate viral fusion.
What diseases are linked to defects in negative regulation of fusion?
Defects can increase susceptibility to COVID-19, HIV-1, MERS, classical swine fever, Borna disease, and herpes simplex virus infections.
How does daily rhythm affect viral fusion?
Daily rhythms in ACE2, ADAM17, and TMPRSS2 expression can influence the efficiency of viral entry and the impact of negative regulation.
Conclusion
GO:1903914, negative regulation of fusion of virus membrane with host plasma membrane, is a central node in host-pathogen interactions that determines whether a virus can successfully initiate infection. The interplay between host restriction factors such as IFITM proteins, viral countermeasures like ESCRT-III hijacking, and physiological parameters such as calcium and circadian rhythms defines the outcome of viral entry. Continued research using CRISPR models and advanced imaging will uncover new therapeutic targets and broaden our understanding of antiviral immunity.
References
- 1. Cheng Y et al.. 2025. Classical swine fever virus hijacks ESCRT-III and VPS4A to promote phagophore closure for accelerating mitophagy.. Autophagy 21(12):2709-2729 PMID: 40574328
- 2. Rajaure M et al.. 2015. Membrane fusion during phage lysis.. Proc Natl Acad Sci U S A 112(17):5497-502 PMID: 25870259
- 3. Nunberg JH et al.. 2012. The curious case of arenavirus entry, and its inhibition.. Viruses 4(1):83-101 PMID: 22355453
- 4. Straus MR et al.. 2020. Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.. J Virol 94(13) PMID: 32295925
- 5. Marziali F et al.. 2021. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1.. J Virol 95(18):e0043921 PMID: 34160255
- 6. Vu A et al.. 2021. Herpes Simplex Virus 1 UL34 Mutants That Affect Membrane Budding Regulation and Nuclear Lamina Disruption.. J Virol 95(17):e0087321 PMID: 34133898
- 7. Zlacká J et al.. 2021. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.. Physiol Res 70(S2):S177-S194 PMID: 34913351
- 8. Lennartz F et al.. 2016. Surface glycoprotein of Borna disease virus mediates virus spread from cell to cell.. Cell Microbiol 18(3):340-54 PMID: 26332529
